Portable oxygen concentrators are approved by the FAA
for use on airlines. People on oxygen wish to continue usual activities.
Distributors are concentrated on termining which portable oxygen concentrator
allows the freedom to continue a meaningful lifestyle. There are two types of
oxygen delivery systems providing upplemental oxygen therapy; continuous flow
(Respironics SimplyGo, SeQual Eclipes,) and pulse dose (Inogen One G3, AirSep
Freestyle, Invacare XPO2,).
A pulse dose system is the most commonly used
portable oxygen concentrator. because of its light weight and long battery
life, some lasting up to 8 hours on a single battery charge. Some oxygen users
require continuous flow oxygen due to their diagnosis or illness progress.
Continuous flow is required by any oxygen user who is titrating oxygen into
their CPAP or BiPAP therapy.
Major factors driving the market for portable oxygen
concentrators include its ability to provide oxygen under all circumstances.
The worldwide aging population. An increase in the number of people with COPD
and other respiratory diseases. Advantages of portable oxygen concentrator
devices are that they weigh less, are easy to use. They are affordable.
The complexion of the home oxygen market is changing.
Home oxygen markets have been predicated on a dealer infrastructure. These
dealers get reimbursed for regular deliveries of liquid oxygen used for
supplemental oxygen so the patient can go out, buy groceries, go to the movies,
and visit family for a short time. The advent of reliable, inexpensive portable
home oxygen concentrators has changed the market dynamic significantly.
No longer do patients need regular deliveries of
liquid oxygen for supplemental purposes so the patient can go out. Now, the
patient just uses one device at home and while out of the home. The economics
of the medical oxygen market have been changing for a long time. CMS Medicare
and the private insurers that follow their lead have been resisting paying for
supplemental liquid oxygen because the price of truck rolls is too high. With
lowered reimbursement, the dealer distribution network that has been in place
for many years is no longer tenable.
According to Susan Eustis, principal author of the
team that developed the market research study, “Technology has achieved major
breakthroughs for portable oxygen concentrator units. Smaller and lighter units
are of benefit to patients, supporting the ability to carry the devices
easily.” A few companies dominate the portable oxygen concentrator market sector.
Inogen has taken over the market leadership position with improved technology
and innovative marketing. Invacare had carefully nurtured its distribution
network and continues to do so, but the markets are changing with deliveries
from dealers a problem in the industry and for reimbursement, giving Inogen
market advantage. Portable oxygen concentrator market size at $744 million in
2014 is expected grow to $2.2 billion by 2021. Market growth is a result of the
aging of the population and the increased need for oxygen.
Spanning over 659 pages, “Portable Oxygen Concentrators: Market Shares,
Strategy,and Forecasts, Worldwide, 2015 to 2021” report
covers the Portable Oxygen Concentrator Market Shares and Forecasts, Portable
Oxygen Concentrator Market Description and Market Dynamics, Portable Oxygen
Concentrator Market Shares and Forecasts, Portable Oxygen Concentrator Product
Description, Oxygen Concentrator Technology, Portable Oxygen Equipment Company
Description. The report covered few companies are - Inogen Chart / Caire /
SeQual, Philips Respironics AirSep, Invacare Teijin, Drive O2Concepts Oxlife
For further information on this report, please visit- http://mrr.cm/4W3
Find all Medical Devices
Reports at: http://www.marketresearchreports.com/medical-devices
No comments:
Post a Comment
Note: only a member of this blog may post a comment.